3-hydroxyephedrine has been researched along with Ventricular Dysfunction, Left in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carnagarin, R; Chan, JJS; Dwivedi, G; Ho, JK; Kiuchi, MG; Lugo-Gavidia, LM; Matthews, VB; Nolde, JM; Schlaich, MP; Villacorta, H | 1 |
| Aikawa, T; Katoh, C; Magota, K; Manabe, O; Naya, M; Obara, M; Tamaki, N; Tomiyama, Y; Tsutsui, H; Yamada, S | 1 |
| Aoki, H; Chen, WP; Kajinami, K; Kinuya, S; Matsunari, I; Nakajima, K; Nekolla, SG; Nomura, Y; Takeda, N; Taki, J | 1 |
| Kirkwood, I; Larkin, D; Marinescu, V; Pop-Busui, R; Raffel, DM; Schmid, H; Schroeder, J; Stevens, MJ; Yamada, E | 1 |
| Allman, KC; Dayanikli, F; Ficaro, E; Pfeifer, MA; Raffel, DM; Sandford, T; Schwaiger, M; Stevens, MJ; Wieland, DM | 1 |
1 review(s) available for 3-hydroxyephedrine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure-Targeting the Sympathetic Nervous System.
Topics: 3-Iodobenzylguanidine; Animals; Arrhythmias, Cardiac; Catecholamines; Death, Sudden, Cardiac; Disease Models, Animal; Ephedrine; Heart; Heart Failure; Humans; Myocardial Infarction; Myocardium; Positron-Emission Tomography; Sympathetic Nervous System; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2019 |
4 other study(ies) available for 3-hydroxyephedrine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Impaired Myocardial Sympathetic Innervation Is Associated with Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction:
Topics: Aged; Autonomic Nervous System Diseases; Ephedrine; Female; Heart Failure; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Ventricular Dysfunction, Left | 2017 |
Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Ephedrine; Female; Heart; Humans; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Stroke Volume; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction.
Topics: Adenosine; Adult; Autonomic Nervous System Diseases; C-Reactive Protein; Carbon Radioisotopes; Contrast Media; Coronary Circulation; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diastole; Ephedrine; Female; Heart; Heart Conduction System; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Oxidative Stress; Vasoconstriction; Ventricular Dysfunction, Left; von Willebrand Factor | 2004 |
Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk.
Topics: Adult; Analysis of Variance; Carbon Radioisotopes; Denervation; Diabetic Neuropathies; Ephedrine; Female; Heart; Heart Rate; Heart Ventricles; Humans; Image Processing, Computer-Assisted; Male; Neurons; Reference Values; Sympathetic Nervous System; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1998 |